News of Note—Chickenpox outbreak, GeoVax and more

newspaper
In this week's news of note, GeoVax entered a new immunotherapy collaboration. (Pixabay)

Here is some other vaccine news of note for the week:

> A chickenpox outbreak in a North Carolina anti-vaccination hotbed is the state's worst in two decades. The Washington Post article

> GeoVax entered a collaboration with Leidos to test its vaccine candidates in conjunction with Leidos-developed checkpoint inhibitors. Release

> In a preclinical study, a DNA vaccine lowered the buildup of tau and beta-amyloid proteins associated with Alzheimer's disease. Release

Read more on

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.